Cannabis Companies Refinance Debt at Lower Rates—Window Closing Fast

By Sheeba M. | May 31, 2026 Cannabis Companies Refinance Debt at Lower Rates—Window Closing Fast TL;DR: Major MSOs and Canadian LPs are locking in refinancing deals ahead of potential rate hikes. Companies with near-term maturity walls (Curaleaf, Trulieve, Tilray) are most urgent—this window likely closes by Q3 2026. The cannabis capital markets are experiencing […]

Cannabis ETFs See Institutional Buying Ahead of June Rebalancing

By Sheeba M. | May 30, 2026 Cannabis ETFs See Institutional Buying Ahead of June Rebalancing TL;DR: Large-cap cannabis ETFs are experiencing increased institutional inflow as fund managers rebalance portfolios heading into Q2 close. Watch for continued upward pressure on tier-1 operators through month-end. The cannabis sector is seeing a quiet rotation this week as […]

California’s Cultivator Supply Crisis: Why Indoor Grow Ops Are the 2026 M&A Play

By Sheeba M. | May 30, 2026 California’s Cultivator Supply Crisis: Why Indoor Grow Ops Are the 2026 M&A Play TL;DR: California outdoor cannabis supply has collapsed 40% YoY due to drought and regulatory delays. Indoor cultivators with licensed grow capacity are now acquisition targets for MSOs. Curaleaf and Trulieve are quietly building integrated supply […]

Trulieve Q1 Profit Inflection: EBITDA+ Territory After Five-Year Climb

By Sheeba M. | May 30, 2026 Trulieve Q1 Profit Inflection: EBITDA+ Territory After Five-Year Climb TL;DR: Trulieve’s journey from cash-burn to EBITDA profitability marks the inflection point for U.S. MSOs. With 226 stores, Best-in-Class unit economics, and federal tailwinds, TRUL is entering institutional prime time. Trulieve Cannabis (TRUL) reported Q1 2026 results last week—and […]

US MSO Consolidation Accelerates: What Federal Policy Shifts Mean for Your Portfolio

By Sheeba M. | May 30, 2026 US MSO Consolidation Accelerates: What Federal Policy Shifts Mean for Your Portfolio TL;DR: Multi-state operators are consolidating aggressively ahead of potential federal rescheduling, and early movers in this wave will capture the most value when banking access improves and institutional capital floods in. The US cannabis MSO sector […]

Canopy Growth Q4 Earnings Signal Recovery Path in Canadian Market

By Sheeba M. | May 30, 2026 Canopy Growth Q4 Earnings Signal Recovery Path in Canadian Market TL;DR: Canopy Growth’s latest quarterly results show improving margins and cost discipline, with management signaling profitability targets for fiscal 2025—a critical inflection point for Canada’s largest cannabis producer. Canopy Growth (CGC on TSX, CGBF on US OTC) reported […]

Village Green: Daily Cannabis Intelligence Brief

Curated from social media posts and threads 1. Federal Tax Guidance Urgent for Cannabis Businesses Lawmakers press IRS for immediate guidance on Form 280E tax relief following cannabis Schedule III rescheduling. New tax framework could unlock $billions in deductions for MSOs and cultivators operating under federal approval. Read on Marijuana Moment → 2. Medical Cannabis […]

CBD Market Consolidation: Wall Street’s Next Play

By Sheeba M. | May 29, 2026 CBD Market Consolidation: Wall Street’s Next Play TL;DR: As CBD regulations normalize, larger cannabis operators are quietly acquiring standalone CBD brands. This consolidation wave mirrors Big Pharma M&A strategies—expect major announcements from CURLF and TCNNF within 12 months. The CBD market has reached an inflection point. What started […]

Cannabis Retailers Expand Footprint as Market Demand Surges

By Sheeba M. | May 29, 2026 Cannabis Retailers Expand Footprint as Market Demand Surges TL;DR: Major cannabis retailers are reporting double-digit store growth as normalized markets attract mainstream investment. Watch retailers like TRSSF and GTBIF for Q2 expansion announcements. The U.S. cannabis retail landscape is entering a critical expansion phase. With roughly half the […]

📅 Yesterday's News & Older Articles →